• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Insight
11 min read 13th April 2017

The Long-term Sustainability of the NHS and Adult Social Care

On 5th April 2017 the House of Lords Select Committee on the Long-term Sustainability of the NHS published their report titled “The Long-term Sustainability of the NHS and Adult Social Care”. The report provides a series of recommendations for the…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

On 5th April 2017 the House of Lords Select Committee on the Long-term Sustainability of the NHS published their report titled “The Long-term Sustainability of the NHS and Adult Social Care”. The report provides a series of recommendations for the government in order to improve the outlook for the NHS.

On 5th April 2017, the House of Lords Select Committee on the Long-term Sustainability of the NHS published a report of their inquiry into the sustainability issues facing the NHS: “The Long-term Sustainability of the NHS and Adult Social Care”.

The report is critical of previous efforts to effectively plan for the long-term future of the NHS, and provides a series of challenging recommendations for the government in order to improve the outlook for the NHS.

The recommendations have been welcomed by the likes of the Health Foundation and the Nuffield Trust, as well as many professional organisations. It has previously been suggested that 30-40% of Select Committee recommendations end up as government policy, but will this happen here?

As detailed below, one of the recommendation is ‘realistic and consistent funding’, but adequate funding underpins all of the recommendations. The elephant in the room is where this funding will come from: higher taxation or cutting funding to other public services. If the general public are unwilling to pay more taxes to fund the NHS, is it realistic to expect that these recommendations will be implemented?

Key recommendations from the report include:

1.       The Establishment of an Office for Health and Care Sustainability

The Select Committee state that there is a culture of short-termism in the NHS and adult social care, where the future is left to ‘take care of itself’. They propose that an Office for Health and Care Sustainability is established to look 15-20 years ahead into the future. This office should focus on:

  1. the monitoring and publication of authoritative data relating to changing demographic trends, disease profiles and the expected pace of change relating to future service demand;
  2. the workforce and skills mix implications of these changes; and
  3. the stability of health and adult social care funding allocations relative to that demand, including the alignment between health and adult social care funding.

2.       Transforming Services

A renewed drive to integrate health and social care is badly needed. The Select Committee state that service transformation is key to achieving this goal and that with this focus there is no need for NHS England and NHS Improvement to co-exist. Thus, they conclude that the two should be merged to create a new body with “streamlined and simplified regulatory functions”.

3.       Realistic and Consistent Funding for Health and Adult Social Care

The Select Committee state that either a shift in government priorities or an increase in taxation is needed to sustain the NHS. Specifically:

  • Health spending beyond 2020 needs to increase at least in line with GDP.
  • The Government needs to provide further funding between now and 2020 for social care (beyond 2020 funding increases should be aligned with NHS funding increases at a minimum).
  • Budgetary responsibility for adult social care at a national level should be transferred to the Department of Health.
  • There should be a funding system for social care that enables those who can afford it to pay for the care they need but with the costs falling on individuals capped in the manner proposed by the Dilnot Commission .
  • The Government should give serious consideration to an insurance-based scheme which would start in middle-age to cover care costs.

4.       The absence of long-term workforce planning

The Select Committee state that the biggest internal threat to the sustainability of the NHS is the inability to secure an appropriately skilled and committed workforce. Specifically they report that Health Education England needs to be substantially strengthened and transformed into an integrated strategic workforce planning body for health and social care with a rolling 10-year outlook.

5.       Innovation, technology and productivity

It should be made clear that the adoption of innovation and technology, after appropriate appraisal, across the NHS is a priority and the Government should decide who is ultimately responsible for this overall agenda.

Additionally, a newly unified NHS England and NHS Improvement should work with commissioners to achieve greater levels of consistency in NHS efficiency and performance at a local level.

6.       Public health, prevention and patient responsibility

The Select Committee state that continued cuts to the public health budget are short-sighted and counter-productive. The burden of disease could increase if these cuts continue, which is bound to result in a greater strain on all services. Therefore they recommend that the Government restores the funds which have been cut in recent years and maintain ring-fenced public health budgets for the next 10 years at a minimum.

Additionally, the Select Committee recommend that the Government is clear with the public that access to the NHS involves patient responsibilities as well as patient rights. They recommend that the NHS Constitution is redrafted and relaunched with a greater emphasis on these individual responsibilities.

Further information:

Watch or read evidence  given to the committee by leading health economists: Professor Alistair McGuire; Professor Andrew Street.

Listen to John Appleby’s (Nuffield Trust) Radio 4 programme entitled: Can the NHS Survive?

  • Health Care Systems
  • Policy, Organisation and…
  • Health Policy and Regulation

Related Insights

Slide3
  • Insight
  • October 2022

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

Read more
PatientPayer_Adobe_missizio01-scaled-1
  • Insight
  • June 2022

The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis

Read more
Krankenschwestern mit Arzt, Generative KI
  • Insight
  • May 2022

Ignoring the needs of our future workforce could have disastrous consequences for the UK NHS and its patients.

Read more
  • Insight
  • February 2022

How Does Pharmaceutical Spending Drive Innovation in Europe?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!